Ethosuximide Capsule
Product Images NDC 42806-708

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethosuximide (NDC 42806-708). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250mg-100ct.jpg (250mg 100ct)

250mg-100ct.jpg (250mg 100ct)
Label for Ethosuximide Capsules USP 250 mg by Epic Pharma, LLC. The label includes dosage instructions, storage conditions, and a note on dispensing in a child-resistant container. It states the package contains 100 oral capsules. Manufactured by Humanwell PuraCap Pharmaceutical in Wuhan, China. The label also features a barcode and warnings to keep medication out of reach of children.*
FDA Label Image

Structure-formula.jpg (Image 01)

Structure-formula.jpg (Image 01)
Chemical structure of Ethosuximide showing its molecular framework, including two carbonyl groups, a nitrogen atom in a ring structure, and ethyl and methyl side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.